FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1

Silvana Mourón(Spanish National Cancer Research Centre), María J. Bueno(Spanish National Cancer Research Centre)
Breast Cancer Research
February 12, 2021
Cited by 52


Related Papers